Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method

The Journal of Pharmacy and Pharmacology
Daisuke TsunashimaKazutaka Higaki

Abstract

Tacrolimus is a poorly water-soluble compound that is used to prevent allograft rejection. We aimed to prepare an extended release formulation of tacrolimus to achieve both an extended release profile and improved solubility of tacrolimus. Extended release granules (ERG) of tacrolimus were prepared with lactose, ethylcellulose (EC) and hydroxypropylmethylcellulose (HPMC) via the solvent evaporation method. In an in vitro release study, ERG had an extended release profile, and the release rate of tacrolimus was regulated by the quantity of lactose, EC and HPMC in the formulation. HPMC-containing ERG successfully enhanced and maintained supersaturation of tacrolimus even after 24 h in a supersaturated release study. In contrast, the extent of supersaturation rapidly decreased after 4 h and the concentration nearly reached the same level as that of crystalline tacrolimus at 24 h for ERG without HPMC. In vivo absorption characteristics were compared between ERGs and immediate release (IR) formulation of tacrolimus. Successful and sustained absorption of tacrolimus without reducing bioavailability compared with IR formulation was observed for ERG. These results suggest the feasibility of combining an EC-based formulation with solid ...Continue Reading

References

Dec 1, 1995·Clinical Pharmacokinetics·R VenkataramananT Starzl
Sep 12, 2000·Journal of Pharmaceutical Sciences·K Khougaz, S D Clas
Aug 18, 2001·Journal of Microencapsulation·S J CheuW J Lin
Sep 19, 2002·Drug Development and Industrial Pharmacy·L H EmaraA Abd Elbary
Nov 7, 2003·International Journal of Pharmaceutics·Kazunari YamashitaToshikiro Kimura
Jan 22, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Karel SixGuy Van den Mooter
Nov 5, 2005·Alimentary Pharmacology & Therapeutics·C SchillerW Weitschies
Mar 21, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nobuyuki TanakaToshikiro Kimura
Jun 15, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Philip P Gerbino, Omar Shoheiber
Sep 30, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Taher NassarSimon Benita
May 13, 2009·Molecular Pharmaceutics·James C DiNunzioRobert O Williams
May 28, 2011·Drug Development and Industrial Pharmacy·Yongjun WangZhonggui He
Mar 13, 2012·International Journal of Pharmaceutics·Takatsune YoshidaAkihiko Kikuchi
Mar 14, 2013·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Celia CifuentesIsidoro Caraballo
Sep 10, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Zong-Zhu PiaoBeom-Jin Lee
Sep 10, 2013·International Journal of Pharmaceutical Investigation·Pranav V PatelTejal A Mehta
Jan 7, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jung Hyun ChoHan-Gon Choi

❮ Previous
Next ❯

Citations

Mar 10, 2017·Drug Development and Industrial Pharmacy·Weiqin WangHuixia Lv
Jan 7, 2020·Transplantation Proceedings·Bernhard BanasNasrullah Undre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.